Junwei Cheng

机构：Sino Biopharmaceutical (China), Celldex Therapeutics (United States) · ORCID：0000-0003-3159-5222

发表论文 19 篇 · 总被引 409 次 · h-index 13

代表论文

• Multimodal deep learning using on-chip diffractive optics with in situ training capability (2024 · Nature Communications · 被引 119)
• Assessing the Potential of New Lignin-Based pH-Responsive Nanoparticles as Drug Carriers for Cancer Treatment (2022 · ACS Sustainable Chemistry & Engineering · 被引 37)
• Hypersensitive MR angiography based on interlocking stratagem for diagnosis of cardiac-cerebral vascular diseases (2023 · Nature Communications · 被引 34)
• Dual-stimuli responsive smart nanoprobe for precise diagnosis and synergistic multi-modalities therapy of superficial squamous cell carcinoma (2023 · Journal of Nanobiotechnology · 被引 29)
• Cell membrane-based nanomaterials for theranostics of central nervous system diseases (2023 · Journal of Nanobiotechnology · 被引 26)
• Red Blood Cell Membrane-Coated Ultrasmall NaGdF4 Nanoprobes for High-Resolution 3D Magnetic Resonance Angiography (2022 · ACS Applied Materials & Interfaces · 被引 26)